Genetically Encoded Multivalent Elastin-Like Polypeptide-Haemadin Fusion Proteins for Prolonged Antithrombotic Protection

The clinical application of peptide therapeutics is often constrained by their short plasma half-life, necessitating frequent administration and resulting in undesirable pharmacokinetic fluctuations and side effects. Here, we developed a genetically encodable multivalent fusion protein platform that combines haemadin, a selective thrombin inhibitor derived from terrestrial leeches, with an elastin-like polypeptide (ELP) partner via factor Xa (FXa)-cleavable peptide linkers. This platform enables tunable drug loading, long-term release, and stimuli-responsive activation of antithrombotic activity. After subcutaneous injection, the fusion protein undergoes temperature-triggered ELP condensation to form an in situ depot that slowly releases an inactivated prodrug, which remains inert in circulation until thrombus-associated FXa cleave the linker to liberate active haemadin on demand. We achieved high-yield expression and facile nonchromatographic purification of the fusion protein. Subcutaneous administration resulted in significant prolongation of antithrombotic protection postinjection. This approach holds strong potential to enhance the safety, efficacy, and dosing convenience of peptide therapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

The clinical application of peptide therapeutics is often constrained by their short plasma half-life, necessitating frequent administration and resulting in undesirable pharmacokinetic fluctuations and side effects.

Leech-derived molecules this paper discusses, each with a full profile in the ASH compound registry:

Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist

More peer-reviewed studies in Arzneimittelentwicklung.

• Novel Leech Antimicrobial Peptides — Hirunipins — Kumar et al. (2025)
• Medicinal Leech Genome Assembly — Anticoagulant Gene Catalog — Kvist et al. (2020)
• Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
• Hirudotherapy in Medicine and Dentistry — Jha K et al. (2015)
• Medicinal leech therapy (hirudotherapy): a brief overview — Singh A (2010)
• HIRUDOTHERAPY IN PRESBYACUZIS PRAECOX IN CLEAN-UP WORKERS AFTER THE CHORNOBYL ACCIDENT DURING THE POST-CATASTROPHE YEARS — Zabolotnyi D, Mishchanchuk N (2019)
• Investigation of oxidant-antioxidant status in patients treated with hirudotherapy: an experimental study — Sarikan I, Savas H (2024)
• Leech therapeutic applications — Abdualkader A et al. (2013)
• Non-Occlusive Mesenteric Ischemia Due to Hirudotherapy: A Case Report — Akalın Ç, Ekmen N (2020)
• Leech therapy: a history — Hyson J (2005)

Browse all ASH-analysed research →